Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.88 USD | -2.65% | +2.32% | -13.89% |
May. 07 | TD Cowen Adjusts BioNTech Price Target to $98 From $95, Maintains Hold Rating | MT |
May. 07 | BMO Capital Adjusts BioNTech Price Target to $122 From $123, Maintains Outperform Rating | MT |
Evolution of the average Target Price on BioNTech SE
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering BioNTech SE
JEFFERIES | Akash Tewari |
GOLDMAN SACHS | Chris Shibutani |
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
UBS | |
TD Cowen | |
alphavalue | Martin Schnee |
BMO Capital | |
Canaccord Genuity | |
HC Wainwright | |
Oppenheimer | |
Morgan Stanley | |
JPMorgan Chase | |
JPMORGAN | Jessica Fye |
HSBC | |
Deutsche Bank Securities | |
BERENBERG | Zhiqiang Shu |
Redburn | |
Berenberg Bank | |
BofA Securities | |
Jefferies & Co. | |
SVB Securities LLC | |
Kempen | |
DEUTSCHE BANK | Emmanuel Papadakis |
SVB Leerink | |
BRYAN GARNIER | Olga Smolentseva |
Bryan, Garnier & Co. | |
Wolfe Research | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- BNTX Stock
- Consensus BioNTech SE